Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Coley begins phase II trials with CpG compound

Oct. 23, 2000

NIH grant for acute lung injury research goes to CollaGenex

Oct. 23, 2000

SB reports discovery of CCR3 receptor antagonists and potential applications thereof

Oct. 20, 2000

Elan receives patent coverage for new integrin receptor antagonists

Oct. 19, 2000

Aradigm completes phase II trial with AERx delivery of dornase alfa for CF patients

Oct. 18, 2000

Chemokine receptor-modulating pyrrolidine compounds in the Merck pipeline

Oct. 16, 2000

EMEA issues positive recommendation for Schering-Plough's desloratadine

Oct. 13, 2000

New PDE4 inhibitors and methods of treating asthma

Oct. 10, 2000

Salus receives SBIR grant for cystic fibrosis research

Oct. 10, 2000

AxyS selects lead compound in asthma program

Oct. 10, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...